0002039280-25-000003.txt : 20250926 0002039280-25-000003.hdr.sgml : 20250926 20250926083302 ACCESSION NUMBER: 0002039280-25-000003 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20250926 DATE AS OF CHANGE: 20250926 EFFECTIVENESS DATE: 20250926 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mission BioCapital VI LP CENTRAL INDEX KEY: 0002039280 ORGANIZATION NAME: EIN: 934782451 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-525216 FILM NUMBER: 251345512 BUSINESS ADDRESS: STREET 1: 139 MAIN STREET, SUITE 401 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-276-5578 MAIL ADDRESS: STREET 1: 139 MAIN STREET, SUITE 401 CITY: CAMBRIDGE STATE: MA ZIP: 02142 D/A 1 primary_doc.xml X0708 D/A LIVE 0002039280 Mission BioCapital VI LP 139 MAIN STREET, SUITE 401 CAMBRIDGE MA MASSACHUSETTS 02142 617-276-5578 DELAWARE None None Limited Partnership true 2023 General Partner Mission BioCapital VI GP LLC 139 Main Street, Suite 401 Cambridge MA MASSACHUSETTS 02142 Promoter General Partner of the Issuer Peter D. Parker 139 Main Street, Suite 401 Cambridge MA MASSACHUSETTS 02142 Executive Officer Manager of the General Partner of the Issuer Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.1 3C.7 true 0002039280-24-000001 2024-09-30 false true false 0 BHA Select Network, LLC 168883 None None 1 Lincoln St. 29th Floor Boston MA MASSACHUSETTS 02111 All States false Indefinite 133750000 Indefinite false 9 156000 0 The Placement Agent's fees are dependent on the capital raised and will be paid by Mission BioCapital Management Company LLC. 0 The General Partner of an affiliate may be entitled to receive a management fee or carried interest in in accordance with the Issuer's governing documentation, as amended from time to time. The amount of fees cannot be estimated at this time. false Mission BioCapital VI LP /s/ Peter D. Parker Peter D. Parker Manager of the General Partner of the Issuer 2025-09-26